Upstream oversight assessment for agrifood nanotechnology: A case studies approach

Risk Analysis

Volumn 28, Issue 4, 2008, Pages 1081-1098

  Kuzma, Jennifer ^a   Romanchek, James ^a   Kokotovich, Adam ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Agriculture; Food; Nanotechnology; Oversight; Risk

Indexed keywords

ACCIDENT PREVENTION; CANNING; FOOD PRESERVATION; LAWS AND LEGISLATION; NANOTECHNOLOGY; OCCUPATIONAL RISKS; RISK ANALYSIS; RISK MANAGEMENT; SAFETY ENGINEERING; TECHNOLOGY;

AGRICULTURE; AGRIFOOD; CASE STUDIES; EMERGING APPLICATIONS; FOOD; MARKET ENTRY; NOVEL APPLICATIONS; OVERSIGHT; POLICY-MAKERS; REGULATORY POLICIES; REGULATORY SYSTEMS; RISK; SOCIAL CONCERNS;

RISK ASSESSMENT;

AGRICULTURAL CHEMICAL; CELLULOSE; NANOCOATING; NANOCOMPOSITE; NANOCRYSTAL; NANOPARTICLE; NANOSPHERE;

AGRICULTURAL PRODUCTION; ASSESSMENT METHOD; FINANCIAL PROVISION; FOOD MARKET; FOOD POLICY; FOOD PRODUCTION; NANOTECHNOLOGY; POLICY MAKING; RISK ASSESSMENT;

AGRICULTURE; AGROECOSYSTEM; ANIMAL HUSBANDRY; ARTICLE; CASE STUDY; ECOSYSTEM; FOOD PACKAGING; FOOD SAFETY; HYDROLOGY; METHODOLOGY; NANOENCAPSULATION; NANOTECHNOLOGY; PRODUCT DEVELOPMENT; RISK ASSESSMENT; UPSTREAM OVERSIGHT ASSESSMENT;

AGRICULTURE; FOOD; NANOTECHNOLOGY; RISK ASSESSMENT;

EID: 48349093922     PISSN: 02724332     EISSN: 15396924     Source Type: Journal    
DOI: 10.1111/j.1539-6924.2008.01071.x     Document Type: Article

References (115)

1. ABA Section of Environment, Energy and Resources 2006). CAA Nanotechnology Briefing Paper, CERCLA Nanotechnology Issues, CWA Nanotechnology Briefing Paper, EMS/Innovative Regulatory Approaches, The Adequacy of FIFRA to Regulate Nanotechnology-Based Pesticides, RCRA Regulation of Wastes from the Production, Use, and Disposal of Nanomaterials, Regulation of Nanoscale Materials Under the Toxic Substances Control Act. Retrieved August 8, 2007. Available at http://www.abanet.org/environ/nanotech/.
2. Blum, S. A. E., Lorenz, M. G., & Wackernagel, W. (1997). Mechanism of retarded DNA degradation and prokaryotic origin of dnases in nonsterile soils. Systematic and Applied Microbiology, 20 (4 513 521.
3. California EPA 2003). Department of Pesticide Regulation; Toxicology Data Review Summaries. 1-Naphthaleneacetic acid, 1-Naphthaleneacetic Acid Sodium Salt, 1-Naphthaleneacetic Acid, Ethyl Ester, and 1-Naphthaleneacetamide. Retrieved July 23, 2007. Available at http://www.cdpr.ca.gov/docs/toxsums/ toxsumlist.htm.
4. CDC 2007). Disease Listing, E. coli 0157:H7. Available at http://www.cdc.gov/ncidod/dbmd/diseaseinfo/escherichiacoli_g.htm, accessed May 9, 2007.
5. Chen, H., Weiss, J., & Shahidi, F. (2006). Nanotechnology in nutraceuticals and functional foods. Food Technology, 30 36.
6. Choi, Y., & Simonsen, J. (2006). Cellulose nanocrystal-filled carboxymethyl cellulose nanocomposites. Journal of Nanoscience and Nanotechnology, 6 (3 633 639.
7. Chu, S. -C., Keung, J. K., & Su, T-K. (2003). U.S. Patent Application 6599622. July 29.
8. Currall, S. C., King, E. B., Lane, N., Madera, J., & Turner, S. (2006). What drives public acceptance of nanotechnology? Nature Nanotechnology, 1, 153 5.
9. CWA 1977). Clean Water Act. 33 U.S.C. 1251 et seq.
10. Davies, C. (2006). Managing the Effects of Nanotechnology. PEN 2. Project on Emerging Nanotechnologies. Washington, DC.
11. st Century. PEN 9 Project on Emerging Nanotechnologies. Washington, DC.
12. De Campos, A. M., Diebold, Y., Carvalho, E. L., Sanchez, A., & Alonso, M. J. 2004). Chitosan nanoparticles as new ocular drug delivery systems: In vitro stability, in vivo fate, and cellular toxicity. Pharmaceutical Research, 21 (5 803 110.
13. Dieter, M. P., Goehl, T. J., Jameson, C. W., Elwell, M. R., Hildebrandt, P. K., & Yuan, J. H. (1993). Comparison of the toxicity of citral in F344 rats and B6C3F1 mice when administrated by microencapsulation in feed or by corn-oil gavage. Food and Chemical Toxicology, 31 (7 463 474
14. EPA 1998). Guidelines for ecological risk assessment. Federal Register, 63 (93 26846 26924.
15. EPA 2003). National Pollutant Discharge Elimination System (NPDES) Permit Regulation and Effluent Limitation Guidelines and Standards for Concentrated Animal Feeding Operations (CAFOs); Final Rule, 40 CFR Parts 9, 122, 123, and 412.
16. EPA 2005). Science Policy Council. Nanotechnology White Paper. December.
17. EPA 2006a). Office of Pesticide Programs Biopesticide Active Ingredient Factsheet - Chitosan; Poly-D-glucosamine (128930). Available at http://www.epa.gov/pesticides/biopesticides/ingredients/factsheets/ factsheet_128930.htm, accessed May 19, 2007.
18. EPA 2006b). Polluted Runoff (Nonpoint Source Pollution). Available at http://www.epa.gov/owow/nps/, accessed Feb 21, 2007.
19. EPA 2007). Nanoscale materials stewardship program and inventory status of nanoscale substances under the Toxic Substances Control Act; Notice of Availability. Federal Register, 72 (133 38083 38085.
20. Evenson, C. J., & Strevett, K. A. (2006). Discriminant analysis of fecal bacterial species composition for use as a phenotypic microbial source tracking method. Research in Microbiology, 157 (5 437 444.
21. Farm Chemicals Handbook 2002). Willoughby, OH : Meister Publishing Co.
22. FDA 1995). U.S. Food and Drug Administration Center for Food Safety and Applied Nutrition CFSAN Handout: 1995 FDA's Policy for Foods Developed by Biotechnology. Available at http://vm.cfsan.fda.gov/∼lrd/biopolcy.html.
23. FDA 1998). Center for Devices and Radiological Health. Guidance for the Content of Premarket Notificatioin for Hemodialysis Delivery Systems, August 7.
24. FDA 1999). Sunscreen drug products for over the counter human use: Final monograph. Federal Register, 64, 27666 27693.
25. FDA 2002). Food Additives: Food Contact Substance Notification System. 21 CFR Parts 20, 58, 170, 171, 174, and 179.
26. FDA 2003). Substances Generally Recognized as Safe. Available at http://www.cfsan.fda.gov/∼lrd/fcf182.html.
27. FDA 2005). CFSAN/Office of Food Additive Safety. Guidance for Industry: Submitting Requests Under 21 CFR 170.39 Threshold of Regulation For Substances Used in Food-Contact Articles. Available at http://www.cfsan.fda.gov/∼dms/ torguid.html, accessed, May 18, 2007.
28. FDA 2006a). FDA Regulation of Nanotechnology Products. Available at http://www.fda.gov/nanotechnology/regulation.html, accessed February 1, 2007.
29. FDA 2006b). CFSAN/Office of Food Additive Safety. Inventory of Effective Premarket Notifications for Food Contact Substances. Available at http://www.cfsan.fda.gov/∼dms/opa-fcn.html, accessed May 18, 2007.
30. FDA 2006c). Medical Devices, Therapeutic Devices. 21 CFR 876.5820, 5860. Available at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch. cfm?FR=876.5820, accessed May 24, 2007.
31. FDA 2007a). U.S. Food and Drug Administration Center for Veterinary Medicine. CMV and Animal Food, Feed Ingredients, and Additives. Available at http://www.fda.gov/cvm/animalfeed.htm, accessed February 7, 2007.
32. FDA 2007b). U.S. Food and Drug Administration Center for Veterinary Medicine. Animal Feed Safety System. Available at http://www.fda.gov/cvm/AFSS. htm, accessed May 9, 2007.
33. FDA 2007c). Nanotechnology: A Report of the U.S. Food and Drug Administration Nanotechnology Task Force. July 25, 2007.
34. FDAMA 1997). Food And Drug Administration Modernization Act of 1997. P L 105-115.
35. FFDCA 1906). Federal Food, Drug, and Cosmetic Act. 21 U.S.C. 301 et seq.
36. FIFRA 1947, 1972, 1996). Federal Insecticide, Fungicide, and Rodenticide Act 1972. (Amended by the Food Quality Protection Act 1996). 7 U.S.C. 136 et seq.
37. FMIA 1907). Federal Meat Inspection Act. 21 U.S.C. 601 695.
38. Frankel, M. S., & Chapman, A. R. (2001). Genetic technologies: Facing inheritable genetic modifications. Science, 292, 1303.
39. Frazer, L. (2004). Formula for a new foam. Environmental Health Perspectives, 112 (11 A632 A635.
40. Frewer, L. J., Howard, C., Hedderley, D., & Shepherd, R. (1996). What determines trust in information about food-related risks? Underlying psychological constructs. Risk Analysis, 16 (4 473 486.
41. Frewer, L., Lassen, J., Kettlitz, B., Scholderer, J., Beekman, V., & Berdal, K. G. (2004). Societal aspects of genetically modified foods. Food and Chemical Toxicology, 42, 1181 1193.
42. Gill, R 2003). Nano- and Micro-Encapsulation of Food Additives and Agrochemicals. USDA Grant Proposal 2003-00331.
43. Gosselin, R. E., Smith, R. P., & Hodge, H. C. (1984). Clinical Toxicology of Commercial Products, 5th ed. Baltimore, MD : Williams and Wilkins.
44. Guston, D. H., & Sarewitz, D. (2002). Real-time technology assessment. Technology in Society, 24, 93 109.
45. Hett, A. (2004). Nanotechnology: Small Matter Many Unknowns. Zurich, Switzerland : Swiss Reinsurance.
46. Huang, M., Khor, E., & Lim, L. (2004). Uptake and cytotoxicity of chitosan molecules and nanoparticles: Effects of molecular weight and degree of deacetylation. Pharmaceutical Research, 21 (2 344 353.
47. ICTA 2006). International Center for Technology Assessment. Petition Requesting FDA Amend its Regulations for Products Composed of Engineered Nanoparticles Generally and Sunscreen Drug Products Composed of Engineered Nanoparticles Specifically. Retrieved November 19, 2007. Available at http://www.icta.org/doc/Nano%20FDA%20petition%20final.pdf.
48. ICTA 2007). International Center for Technology Assessment. Principles for the Oversight of Nanotechnologies and Nanomaterials. August 5, 2007. Retrieved August 8, 2007. Available at http://www.icta.org/doc/ Principles%20for%20the%20Oversight%20of%20Nanotechnologies%20and%20 Nanomaterials_final.pdf.
49. James, H. Jr. 2006). Trust in scientists and food manufacturers. Journal of Agribusiness, 24 (2 119 133.
50. Jasanoff, S. (2005). Food for thought. Designs on Nature (pp. 119 145) Princeton, NJ : Princeton University Press.
51. Kalaitzandonakes, N. G. (2000). Agrobiotechnology and competitiveness. American Journal of Agricultural Economics, 82 (5 1224 1233.
52. Kotkoskie, L. A., Butt, M. T., Selinger, E., Freeman, C., & Weiner, M. L. (1996). Qualitative investigation of uptake of fine particle size microcrystalline cellulose following oral administration in rats. Journal of Anatomy, 189 (3 531 535.
53. Kumar, M. N. V. R., Bakowsky, U., & Lehr, C. M. (2004). Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials 25 (10 1771 1777.
54. Kuzma, J. (2006). Nanotechnology oversight: Just do it. Environmental Law Reporter, 36, 10913 10920.
55. Kuzma, J. (2007). Moving forward responsibility: Oversight for the nanotechnology-biology interface. Journal of Nanoparticle Research, 9, 165 182.
56. Kuzma, J., & Verhage, P. (2006). Nanotechnology in Agriculture and Food Production. PEN4. Woodrow Washington, Project on Emerging Nanotechnologies.
57. Lagarón, J. M., Cabedo, L., Cava, D., Feijoo, J. L., Gavara, R., & Gimenez, E. (2005). Improving packaged food quality and safety. Part 2: Nanocomposites. Food Additives & Contaminants, 22 (10 994 998.
58. Latour, R. A., Stutzenberger, F. J., Sun, Y. P., Rodgers, J., & Tzeng, T. R. (2003). Adhesion-Specific Nanoparticles for Removal of Campylobacter Jejuni from Poultry. CSREES Grant (2000-2003), Clemson Univ., S.C. Available at http://www.clemson.edu.
59. Lau, O., & Wong, S. K. (2000). Contamination in food from packaging material. Journal of Chromatography, 882 (1-2 255 270.
60. Leung, A. Y., & Foster, S. (1996). Acacia. In Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics (p. 5). New York : John Wiley & Sons, Inc.
61. Lewis, R. J 1996). 1-Naphthaleneacetic acid. In Sax's Dangerous Properties of Industrial Materials (p. 2373 9th ed. Volumes 1-3. New York : Van Nostrand Reinhold.
62. Luo, D., & Saltzman, M. W. (2000). Synthetic DNA delivery systems. Nature Biotechnology, 18, 33 37.
63. Macnaghten, P., Kearnes, M. B., & Wynne, B. (2005). Nanotechnology, governance, and public deliberation: What role for the social sciences? Science Communication, 27 (2 268 291.
64. Macoubrie, J. (2005). Informed Public Perceptions of Nanotechnology and Trust in Government. Washington, DC : Project on Emerging Nanotechnologies.
65. Macoubrie, J. (2006). Nanotechnology: Public concerns, reasoning, and trust in government. Public Understanding of Science, 15, 221 241.
66. Maynard, A. (2006). Nanotechnology: A Research Strategy for Addressing Risk. PEN 3. Washington, DC : Project on Emerging Nanotechnologies.
67. Moghimi, S. M. (2002). Chemical camouflage of nanospheres with a poorly reactive surface: Towards development of stealth and target-specific nanocarriers. Biochimica et Biophysica Acta, 1590, 131 139.
68. Molugu, S., Qu, L., Lin, Y., Sun, Y. P., Tzeng, T. R., Stutzenberger, F. J., & Latour, R. A. (2006). In vitro and in vivo biocompatibility of mannosylated polystyrene nanoparticles. Journal of Biomedical Nanotechnology, 2 (1 1 10.
69. Nanocor 2007). Product/Technical Data Sheets. Available at http://www.nanocor.com/, accessed May 10, 2007.
70. NEPA 1969). National Environmental Protection Act. Pub. L. 91-190, 42 U.S.C. 4321-4347, January 1, 1970, as Amended by Pub. L. 94-52, July 3, 1975, Pub. L. 94-83, August 9, 1975, and Pub. L. 97-258, § 4(b), Sept. 13, 1982.
71. NIH 1982). Carcinogenesis Bioassay of Gum Arabic in F344 Rats and B6C3F1 Mice. Technical Report Series No. 227 Publication No. 82-1783.
72. NNI 2007). National Nanotechnology Initiative: What Is Nanotechnology? Available at http://www.nano.gov/html/facts/whatIsNano.html, accessed May 18, 2007.
73. NRC (National Research Council) 1983). Risk Assessment in the Federal Government. Washington, DC : National Academy Press.
74. NRC (National Research Council) 1996). Understanding Risk. Washington, DC : National Academy Press.
75. NRC, National Research Council 1998). Ensuring Safe Food: From Production to Consumption. Washington, DC : National Academy Press.
76. NRC (National Research Council) 2000). Genetically Modified Pest-Protected Plants: Science and Regulation. Washington, DC : National Academy Press.
77. NTP 2003). Toxicology and carcinogenesis studies of citral (microencapsulated) (CAS No. 5392-40-5) in F344/N rats and B6C3F1 mice (feed studies). National Toxicology Program Technical Report Series, 505, 1 268.
78. Oberdorster, G., Oberdorster, E., & Oberdörster, J. (2005). Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environmental Health Perspectives, 113, 823 839.
79. Ochman, H., Lawrence, J. G., & Wang, E. A. (2000). Lateral gene transfer and the nature of bacterial innovation. Nature, 405, 299 304.
80. Olivier, J-C. (2005). Drug transport to brain with targeted nanoparticles. NeuroRx, 2 (1 99 107.
81. O'Neil, M. J. (Ed 2001). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals, 13th ed. Whitehouse Station, NJ : Merck and Co., Inc.
82. Pidgeon, N. (2006). Opportunities and Uncertainties - The British Nanotechnologies Report and the Case for Upstream Societal Dialogue. Conference Paper: VALDOR. Stockholm, Sweden. Available at http://www.congrex.com/ valdor2006/papers/53_Pidgeon.pdf.
83. Porter, M. E. (1991). America's green strategy. Scientific American, 264, 168.
84. PPIA 1957). Poultry Products Inspection Act. 21 U.S.C 601 et seq.
85. Qi, L, Xu, Z., Jiang, X., Li, Y., & Wang, M. (2005). Cytotoxic activities of chitosan nanoparticles and copper-loaded nanoparticles. Bioorganic and Medicinal Chemistry Letters, 15 (5 1397 1399.
86. Rabino, I. (1994). How European and U.S. genetic engineering scientists view the impact of public attention on their field: A comparison. Science,Technology & Human Values, 19, 23 46.
87. Rasmussen, N. (1981). The application of probabilistic risk assessment techniques to energy technologies. Annual Review of Energy, 6, 123 138.
88. Roco, M. (2001). From vision to the implementation of the U.S. national nanotechnology initiative. Journal of Nanoparticle Research, 3 (1 5 11.
89. Roco, M. (2004). Broader societal issues of nanotechnology. Journal of Nanoparticle Research, 5, 181 189.
90. Rowe, G., & Frewer, L. (2000). Public participation methods: A framework for evaluation. Science, Technology & Human Values, 25 (1 3 29.
91. Royal Society and Royal Academy of Engineering 2004). Nanoscience and Nanotechnologies: Opportunities and Uncertainties. London : Royal Society.
92. SDWA 1974). The Safe Drinking Water Act. 42 U.S.C. 300f et seq.
93. Shrader-Frechete, K. (2007). Nanotoxicology and ethical considerations for informed consent. Nanoethics, 1, 47 56.
94. Siegrist, M. (2000). The influence of trust and perceptions of risks and benefits on the acceptance of gene technology. Risk Analysis, 20, 195 204.
95. Siegrist, M., Cousin, M. E., Kastenholz, H., & Wiek, A. (2007b). Public acceptance of nanotechnology foods and food packaging: The influence of affect and trust. Appetite doi : in press.
96. Siegrist, M., Keller, C., Kastenholz, H, Frey, S., & Wiek, A. (2007a). Laypeople's and experts' perception of nanotechnology hazards. Risk Analysis, 27, 59 69.
97. Simonsen, J. (2003). Cellulose Nanocrystal Composites. USDA-CRIS Grant Proposal 2003-02267.
98. Singer, P., & Daar, A. S. (2000). Avoiding franken drugs. Nature Biotechnology, 18, 1225.
99. Slovic, P. (1987). Perception of risk. Science, 236, 280 285.
100. Taylor, M. (2006). Regulating the Products of Nanotechnology: Does FDA Have the Tools it Needs? PEN 5. Washington, DC : Project on Emerging Nanotechnologies.
101. Taylor, M. (2007). Nanotech Will Heat Up. Red Herring. Available at http://redherring.com/article.aspx?a=20691, accessed 22 January 2007.
102. Taylor, S., Qu, L, Kitaygorodskiy, A., Teske, J., Latour, R. A., & Sun, Y-P. (2004). Synthesis and characterization of peptide-functionalized polymeric nanoparticles. Biomacromolecules, 5 (1 245 248.
103. Toumey, C. (2006). Science and democracy. Nature Nanotechnology, 1, 6 7.
104. Townshed, E. (2006). Affective influences on risk perceptions of, and attitudes toward, genetically modified food. Journal of Risk Research, 9 (2 125 139.
105. Trevors, J. (1996). Nucleic acids in the environment. Current Opinion in Biotechnology, 7 (3 331 336.
106. TSCA 1976). The Toxic Substances Control Act. 15 U.S.C. 2601 et seq.
107. Van Noorden, R 2007). Nano-hype comes out in the wash. Chemistry World, January.
108. Vila, A., Sanchez, A., Tobio, M., Calvo, P., & Alonso, M. J. (2002). Design of biodegradable particles for protein delivery. Journal of Controlled Release, 78, 15 24.
109. VSTA 1913). Virus Serum Toxin Act. 21 U.S.C. 151-159.
110. Walter, M. T., Luo, D., & Regan, J. M. (2005). Using Nanotechnology to Identify and Characterize Hydrological Flowpaths in Agricultural Landscapes. USDA-CRIS Grant Proposal 2004-04459.
111. Walter, T. M. (2006). Personal email correspondence. July.
112. WHO 1998). Safety evaluation of certain food additives and contaminants. microcrystalline cellulose. WHO Food Additives Series, 40, 55 78.
113. Wilsdon, J., & Willis, R. (2004). See-Through Science. London : Demos. Available at http://www.demos.co.uk.
114. Yin, R. K. (2002). Case Study Research. Design and Methods. 3rd ed. Applied Social Research Method Series, Volume 5. CA: Sage Publications.
115. Zeng, C., Han, X., Lee, L. J., Koelling, K. W., & Tomasko, D. L. (2003). Polymer-clay nanocomposite foams prepared using carbon dioxide. Advanced Materials, 15 (20 1743 1747.